Listed

Dermata Therapeutics, Inc.

DRMANasdaqCIK 1853816HealthcareFiscal year ends Dec 31

Reports and events: 135 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Dermata Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2025-01-2108:05 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-25-000570
2024-11-1418:03 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-24-014289
2024-11-1316:16 ET10-QQuarterly reportPeriod 2024-09-300001654954-24-014274
2024-09-1717:25 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001654954-24-012031
2024-08-0716:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-24-010104
2024-08-0716:05 ET10-QQuarterly reportPeriod 2024-06-300001654954-24-010103
2024-08-0217:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001654954-24-009903
2024-06-0717:11 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001654954-24-007532
2024-06-0509:02 ET8-K8.01 Other events0001654954-24-007369
2024-05-2416:06 ET8-K3.01 Delisting notice0001654954-24-006912
2024-05-1716:09 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001654954-24-006608
2024-05-1516:07 ET10-QQuarterly reportPeriod 2024-03-310001654954-24-006398
2024-05-1516:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-24-006396
2024-05-1509:00 ET8-K3.01 Delisting notice; 8.01 Other events0001654954-24-006312
2024-05-1409:16 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001654954-24-006133
2024-05-0717:10 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001654954-24-005715
2024-03-2616:26 ETDEF 14AProxy statementPeriod 2024-03-050001654954-24-003656
2024-03-2116:05 ET10-KAnnual reportPeriod 2023-12-310001654954-24-003501
2024-03-2116:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-24-003500
2024-01-1216:06 ET8-K5.07 Shareholder vote results0001654954-24-000520
2023-12-0817:29 ETDEF 14AProxy statementPeriod 2023-12-070001654954-23-015300
2023-11-1716:06 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001654954-23-014542
2023-11-1618:16 ET8-K3.01 Delisting notice0001654954-23-014446
2023-11-0916:09 ET10-QQuarterly reportPeriod 2023-09-300001654954-23-014016
2023-11-0916:08 ET8-K2.02 Results of operations; 4.01 Change of auditor; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-014015
2023-08-1016:18 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-010489
2023-08-1016:16 ET10-QQuarterly reportPeriod 2023-06-300001654954-23-010487
2023-08-0316:31 ET8-K4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001654954-23-010092
2023-07-0716:21 ETS-1Registration statement0001654954-23-008945
2023-06-2316:19 ETDEF 14AProxy statementPeriod 2023-08-030001654954-23-008352
2023-05-2417:13 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-007177
2023-05-1116:07 ET10-QQuarterly reportPeriod 2023-03-310001654954-23-006208
2023-05-1116:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-006209
2023-03-3116:06 ETSC 13D/AOwnership report, active investor, amended0001654954-23-004104
2023-03-3016:06 ETSC 13D/AOwnership report, active investor, amended0001654954-23-003923
2023-03-2817:28 ET10-K/AAnnual report, amendedPeriod 2022-12-310001654954-23-003730
2023-03-2816:06 ET8-K8.01 Other events0001654954-23-003722
2023-03-2016:36 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-003181
2023-03-1609:22 ETS-1/ARegistration statement, amended0001654954-23-002967
2023-03-1519:53 ETS-1/ARegistration statement, amended0001654954-23-002876
2023-03-1317:07 ETS-1/ARegistration statement, amended0001654954-23-002742
2023-03-1313:16 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001654954-23-002711
2023-03-0117:05 ETS-1Registration statement0001654954-23-002273
2023-02-2116:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001654954-23-001927
2023-02-2116:10 ET10-KAnnual reportPeriod 2022-12-310001654954-23-001926
2023-02-0816:05 ET8-K5.07 Shareholder vote results0001654954-23-001476
2023-01-1817:01 ETSC 13D/AOwnership report, active investor, amended0001654954-23-000567
2023-01-1308:00 ETDEF 14AProxy statementPeriod 2023-01-110001654954-23-000377
2022-12-1516:05 ET8-K3.01 Delisting notice; 8.01 Other events0001654954-22-016569
2022-12-0509:01 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001654954-22-016099

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 00:26 ET. Listed shows no prices and gives no investment advice.